Eculizumab for dense deposit disease and C3 glomerulonephritis (Q24632330)

ORCID Public Data File 2021

author name string

Andrew S Bomback

1

0 references

Gaetano R Barile

3

0 references

Yuzhou Zhang

4

0 references

Eliot C Heher

5

0 references

Leal Herlitz

6

0 references

M Barry Stokes

7

0 references

Glen S Markowitz

8

0 references

Vivette D D'Agati

9

0 references

Pietro A Canetta

10

0 references

Jai Radhakrishnan

11

0 references

Gerald B Appel

Clinical Journal of the American Society of Nephrology

12

0 references

language of work or name

English

0 references

publication date

May 2012

0 references

published in

0 references

volume

7

0 references

page(s)

748-56

0 references

issue

5

0 references

cites work

Pre-emptive eculizumab and plasmapheresis for renal transplant in atypical hemolytic uremic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338285

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338285

Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338285

Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338285

Mutations in alternative pathway complement proteins in American patients with atypical hemolytic uremic syndrome

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338285

Causes of alternative pathway dysregulation in dense deposit disease

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338285

Proliferative glomerulonephritis secondary to dysfunction of the alternative pathway of complement

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338285

New treatment options for atypical hemolytic uremic syndrome with the complement inhibitor eculizumab

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338285

Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulation

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338285

C3 glomerulopathy: a new classification

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338285

Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338285

Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338285

Membranoproliferative glomerulonephritis type II (dense deposit disease): an update

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338285

Pathology after eculizumab in dense deposit disease and C3 GN.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338285

Extensive drusen in type I membranoproliferative glomerulonephritis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338285

Eculizumab for paroxysmal nocturnal haemoglobinuria

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3338285

C3 deposition glomerulopathy due to a functional factor H defect

28 November 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22403278